1. Prognostication in Advanced Cancer: A Study Examining an Inflammation-Based Score 
Michael Partridge, MBChB, Marie Fallon, MBChB, MRCGP, FRCP, MD, Caroline Bray, MSc, Donald McMillan, PhD, Duncan Brown, MBChB, MD, FRCP, Barry Laird, MBChB, MRCGP, MD, DRCOG, DFFP 
Journal of Pain and Symptom Management 
Volume 44, Issue 2, Pages (August 2012)
DOI: /j.jpainsymman
Copyright © 2012 U.S. Cancer Pain Relief Committee Terms and Conditions

2. Fig. 1
The relationship between mGPS and survival. The maximum survival times for mGPS 0, 1, and 2 were 57.1, 30.9, and 36.0 weeks, respectively. mGPS=modified Glasgow Prognostic Score.
Journal of Pain and Symptom Management  , DOI: ( /j.jpainsymman )
Copyright © 2012 U.S. Cancer Pain Relief Committee Terms and Conditions